CLINICAL_TRIALS
trial_result
· 2015-01-22
Clinical Trial Update: Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma [Phase 2]
Summary
Phase II trial investigating extended-dosing temozolomide in melanoma completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2015-01-22